Literature DB >> 19370387

Evidence of angiogenic vessels in Alzheimer's disease.

Brinda S Desai1, Julie A Schneider, Jia-Liang Li, Paul M Carvey, Bill Hendey.   

Abstract

Alterations in the blood brain barrier and brain vasculature may be involved in neurodegeneration and neuroinflammation. We sought to determine if vascular remodeling characterized by angiogenic vessels or increased vascular density, occurred in pathologically confirmed Alzheimer's disease (AD) postmortem human brain tissues. We examined brains of deceased, older catholic clergy from the Religious Order Study, a longitudinal clinical-pathological study of aging and AD. The hippocampus, midfrontal cortex, substantia nigra, globus pallidus and locus ceruleus were examined for integrin alphavbeta3 immunoreactivity, a marker of angiogenesis, and vascular densities. Activated microglia cell counts were also performed. All areas except the globus pallidus exhibited elevated alphavbeta3 immunoreactivity in AD cases compared with controls. Only in the hippocampus did the ongoing angiogenesis result in increased vascular density compared with controls. Vascular density was correlated with Abeta load in the hippocampus and alphavbeta3 reactivity was correlated with neurofibrillary tangles in the midfrontal cortex and in the substantia nigra. These data indicate that ongoing angiogenesis is present in brain regions affected by AD pathology and may be related to tissue injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370387      PMCID: PMC2753398          DOI: 10.1007/s00702-009-0226-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  61 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

2.  Vascular basement membrane pathology and Alzheimer's disease.

Authors:  C Zarow; E Barron; H C Chui; L S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  1997-09-26       Impact factor: 5.691

Review 3.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

4.  An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde".

Authors:  A Alzheimer; R A Stelzmann; H N Schnitzlein; F R Murtagh
Journal:  Clin Anat       Date:  1995       Impact factor: 2.414

5.  6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.

Authors:  P M Carvey; C H Zhao; B Hendey; H Lum; J Trachtenberg; B S Desai; J Snyder; Y G Zhu; Z D Ling
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

6.  Collateral growth and angiogenesis around cortical stroke.

Authors:  L Wei; J P Erinjeri; C M Rovainen; T A Woolsey
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

Review 7.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Authors:  Rashid Deane; Berislav V Zlokovic
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

Review 8.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

9.  Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease.

Authors:  S L Siedlak; P Cras; M Kawai; P Richey; G Perry
Journal:  J Histochem Cytochem       Date:  1991-07       Impact factor: 2.479

10.  Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease.

Authors:  Johanna Lahdenranta; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  FASEB J       Date:  2007-05-18       Impact factor: 5.191

View more
  55 in total

Review 1.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

2.  An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity.

Authors:  Aditiben Patel; Giuseppe V Toia; Kalea Colletta; Brinda Desai Bradaric; Paul M Carvey; Bill Hendey
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

Review 3.  Associations between atherosclerosis and neurological diseases, beyond ischemia-induced cerebral damage.

Authors:  Dannia Colín-Castelán; Silvio Zaina
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

4.  Degeneration and repair in central nervous system disease.

Authors:  Eng H Lo
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

5.  An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.

Authors:  Pavitra Kannan; Martin Schain; Warren W Kretzschmar; Lora Weidner; Nicholas Mitsios; Balázs Gulyás; Hans Blom; Michael M Gottesman; Robert B Innis; Matthew D Hall; Jan Mulder
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

7.  The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE.

Authors:  Yi Shu; Bo Xiao; Qian Wu; Tiantian Liu; Yang Du; Haiyun Tang; Si Chen; Li Feng; Lili Long; Yi Li
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

8.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 9.  The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.

Authors:  Paul M Carvey; Bill Hendey; Angela J Monahan
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

10.  The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.

Authors:  Florent Petitprez; Sacha Levy; Cheng-Ming Sun; Maxime Meylan; Christophe Linhard; Etienne Becht; Nabila Elarouci; David Tavel; Lubka T Roumenina; Mira Ayadi; Catherine Sautès-Fridman; Wolf H Fridman; Aurélien de Reyniès
Journal:  Genome Med       Date:  2020-10-06       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.